• Atelopus-zeteki
    link
    fedilink
    198 months ago

    Additional Links: https://medicalxpress.com/news/2024-03-hiv-cell-culture-crispr-cas.html

    https://www.eurekalert.org/news-releases/1038161

    “The authors emphasise that their work represents proof of concept, and will not become a cure for HIV tomorrow. They say: “Our next steps involve optimising the delivery route to target the majority of the HIV reservoir cells. We will combine the CRISPR therapeutics and receptor-targeting reagents and move to preclinical models to study in detail the efficacy and safety aspects of a combined cure strategy. This will be instrumental to achieve preferential CRISPR-Cas delivery to the reservoir cells and avoiding delivery into non-reservoir cells. This strategy is to make this system as safe as possible for future clinical applications. We hope to achieve the right balance between efficacy and safety of this CURE strategy. Only then can we consider clinical trials of ‘cure’ in humans to disable the HIV reservoir. While these preliminary findings are very encouraging, it is premature to declare that there is a functional HIV cure on the horizon.””